Stephanie Link, director of research at TheStreet, says the move in Bristol Myers' stock from the suspension of a Hepatitis C compound has been overdone and sees value in the stock.
TheStreet contributor Nate Sadeghi calls for healthcare investors to start acting like owners.
Stephanie Link, director of research at TheStreet, tells us how to invest in health care given the Obamacare overhang.
The Dow dips and the S&P 500 manages a slight gain despite a weak read on manufacturing activity in June.
Bristol-Myers expands diabetes pipeline with Amylin buy.
©1996-2018 TheStreet, Inc. All rights reserved.Action Alerts PLUS is a registered trademark of TheStreet, Inc.